M. Yu. Gavrilov
M. Yu. Gavrilov publishes mostly in Organic Chemistry, Molecular Biology and Pharmacology, on topics such as Synthesis and Biological Evaluation, Synthesis and Reactions of Organic Compounds and Synthesis and Characterization of Heterocyclic Compounds.
- World rank
- #7,650,850 of 7,710,434 ranked researchers
- Rank in Russia
- #173,036 of 179,717
- Works
- 61
- Citations
- 55
- Citations per work
- 0.9
What does M. Yu. Gavrilov research?
M. Yu. Gavrilov's work is mostly in Chemistry (96%), Biochemistry, Genetics and Molecular Biology (3%), Medicine (1%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences5996.0%
- Chemistry5996.0%
- Life Sciences23.4%
- Health Sciences00.6%
- Medicine00.6%
- 1Organic Chemistry96% of their works
- 2Molecular Biology3% of their works
- 3Pharmacology1% of their works
Research topics
- Synthesis and Biological Evaluation
- Synthesis and Reactions of Organic Compounds
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis of heterocyclic compounds
- Synthesis and biological activity
- Structural and Chemical Analysis of Organic and Inorganic Compounds
- Synthesis and Reactivity of Heterocycles
- Chemical synthesis and pharmacological studies
Which keywords describe M. Yu. Gavrilov's research?
The keywords of their largest research topics: Synthesis, Heterocycles, Biological Evaluation, Heterocyclic Compounds, Catalyst, Anticancer Agents, Medicinal Chemistry and Antimicrobial Activity.
- Properties
- Thiadiazoles
- Indolizines
- Cycloaddition Reactions
- Tubulin Inhibitors
- Annulation
- Anticancer
- Imidazoles
- Derivatives
- Molecular Docking
- Antimicrobial Activity
- Anticancer Agents
- Heterocyclic Compounds
- Heterocycles
- Synthesis
- Biological Evaluation
- Catalyst
- Medicinal Chemistry
- Antimicrobial
- Catalyzed Reactions
- Quinoxaline
- Oxazolones
- Triazines
- Ketene Dithioacetal
- Vascular Targeting Agents
- Bioactivity
- Oxadiazoles
- Heterocyclic Chemistry
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 28 words, with their numbers
- Synthesis1307 topics
- Heterocycles864 topics
- Biological Evaluation643 topics
- Heterocyclic Compounds613 topics
- Catalyst562 topics
- Anticancer Agents522 topics
- Medicinal Chemistry522 topics
- Antimicrobial Activity382 topics
- Antimicrobial352 topics
- Molecular Docking352 topics
- Catalyzed Reactions332 topics
- Derivatives291 topic
- Quinoxaline291 topic
- Imidazoles271 topic
- Oxazolones271 topic
- Anticancer261 topic
- Triazines261 topic
- Annulation241 topic
- Ketene Dithioacetal241 topic
- Tubulin Inhibitors231 topic
- Vascular Targeting Agents231 topic
- Cycloaddition Reactions152 topics
- Bioactivity91 topic
- Indolizines91 topic
- Oxadiazoles91 topic
- Thiadiazoles91 topic
- Heterocyclic Chemistry61 topic
- Properties61 topic
Where does M. Yu. Gavrilov work?
M. Yu. Gavrilov's main affiliation in the publication record is Perm State Pharmaceutical Academy, Russia.
How many publications and citations does M. Yu. Gavrilov have?
OpenAlex counts 61 works and 55 citations for M. Yu. Gavrilov, an h-index of 3, ranking #7,650,850 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about M. Yu. Gavrilov. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.